Sunho Biologics CEO and Chief Scientific Officer Dr. Yin Liusong to Step Down
I'm PortAI, I can summarize articles.
Sunho Biologics, Inc. announced that Dr. Yin Liusong will resign as CEO and Chief Scientific Officer effective February 28, 2026, to pursue other opportunities. He stated there is no disagreement with the board, and he will ensure a smooth transition while the company searches for replacements. This leadership change may impact the company's strategic direction. The current analyst rating for Sunho Biologics (HK:2898) is a Hold with a price target of HK$7.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments